-+ 0.00%
-+ 0.00%
-+ 0.00%

Adial Pharmaceuticals Q4 EPS $(11.48) Misses $(0.09) Estimate

Benzinga·03/06/2026 13:07:27
Listen to the news
Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(11.48) per share which missed the analyst consensus estimate of $(0.09) by 12655.56 percent. This is a 206.13 percent decrease over losses of $(3.75) per share from the same period last year.